Reinforcement learning for policymaking in epidemic control: A scoping review
Clinical Snapshot
PICO Framework
| P — Population | Epidemic control scenarios and populations affected by infectious disease outbreaks |
| I — Intervention | Reinforcement learning algorithms for designing non-pharmaceutical interventions (NPIs) |
| C — Comparator | Heuristic, rule-based, and historical baseline policies |
| O — Outcomes | Infection rates, deaths, lockdown duration, and socio-economic costs |
Bottom Line
This scoping review maps the emerging field of reinforcement learning for epidemic control policy, identifying 13 studies that demonstrate theoretical superiority of RL approaches over traditional rule-based interventions. However, the evidence base is severely limited by small study numbers, lack of real-world validation, simplified economic modeling, and absence of quality assessment. The review reveals significant methodological heterogeneity and highlights critical research gaps including the need for standardized evaluation metrics, robust economic models, and uncertainty quantification. While RL shows theoretical promise for adaptive epidemic response, the current evidence is insufficient to support implementation in real-world public health policy. Healthcare leaders should view this as early-stage research requiring substantial further development, validation, and integration with existing public health frameworks before considering practical application. The field needs rigorous prospective studies and standardized benchmarks before RL can be considered a viable alternative to established epidemic control strategies.
Key Findings
P Value: Not applicable - no statistical analysis
Effect Size: Not quantified - descriptive analysis only
Primary Outcome: RL policies outperformed baseline approaches across infection reduction, mortality, and economic metrics
Nnt Or Sensitivity: Not applicable - mapping review without clinical effectiveness measures
Confidence Interval: Not applicable - no quantitative synthesis
Clinical Application
Low feasibility for immediate implementation - requires significant infrastructure and validation Not directly applicable to Australian healthcare policy without adaptation to local epidemiological models, health system capacity, and regulatory frameworks Limited applicability due to simulation-based evidence and lack of real-world validation
Abstract
BACKGROUND: Managing an epidemic demands policies that respond at the pace of the outbreak. Conventional rule‑based interventions struggle to keep up, prompting interest in reinforcement learning (RL) for designing non‑pharmaceutical interventions (NPIs). However, current evidence is fragmented across diverse models and reporting styles. OBJECTIVES: To systematically map how RL is applied for epidemic NPI design, describe modeling choices, algorithm architectures, evaluation practices, and identify trends and research gaps. METHODS: Peer-reviewed studies (2014-2025, English) that applied deep RL to select NPIs were retrieved from IEEE Xplore, ACM Digital Library, ScienceDirect, and Scopus, searched on December 23, 2025. Reference list scanning supplemented database results. Predefined data items (bibliographic details, epidemic and RL model characteristics, experiments, validation methods, outcomes) were charted and summarized descriptively. RESULTS: Of 512 retrieved records, 10 met the inclusion criteria, and three additional studies were identified via reference-list scanning, yielding 13. Five employed value‑based methods, four policy‑gradient, and four hybrid; one study additionally incorporated model-based planning. Six simulations relied on compartmental models, six on agent‑based models, and one on a hybrid model. Action spaces were predominantly discrete restriction levels. Five studies incorporated sequence-modeling techniques to include temporal context into a state space. Eleven studies designed reward functions as a trade-off between pandemic severity and socio-economic cost. According to the reviewed studies, RL policies across various settings outperform heuristic, rule-based, and historical baselines in reducing infections, deaths, or lockdown duration while limiting economic loss. CONCLUSIONS: RL shows promise for adaptive epidemic control. Comparison is hampered by simplified economic costs, inconsistent calibration rigor, varied evaluation metrics, and limited uncertainty or policy robustness analysis. Future work should establish common benchmark environments and reporting standards, incorporate empirically grounded economic and behavioral models, adopt uncertainty-aware and probabilistic RL, develop more sophisticated control spaces, investigate more advanced algorithms, and validate learned policies prospectively to enable real-world deployment.
References
- 1.Bolshov, O., & Chumachenko, D. (2026). Reinforcement learning for policymaking in epidemic control: A scoping review. PLoS One, 21(1), e0351176. https://doi.org/10.1371/journal.pone.0351176
Related Research
PloS one
Factors associated with resilience among parents of children with autism spectrum disorder: A systematic review
23 June 2026
Cancer
Alcohol consumers' receptivity to artificial intelligence-generated alcohol-cancer risk messages: An experimental study.
15 June 2026
Human vaccines & immunotherapeutics
Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial
14 June 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service